GARDEN BIO-CHEM(300401)2023-10-20 16:00Financial Performance - The company's revenue for Q3 2023 was ¥241,036,935.81, a decrease of 13.21% compared to the same period last year[6] - Net profit attributable to shareholders was ¥31,725,418.22, down 44.10% year-on-year[6] - The net profit excluding non-recurring gains and losses was ¥27,358,452.09, a decline of 49.68% compared to the previous year[6] - Basic earnings per share decreased by 40.00% to ¥0.06, while diluted earnings per share also fell by 40.00% to ¥0.06[6] - Total operating revenue for Q3 2023 was CNY 897,780,746.50, a decrease of 17% compared to CNY 1,078,266,939.50 in Q3 2022[26] - Net profit for Q3 2023 was CNY 148,933,265.99, down 58% from CNY 353,789,983.54 in the same period last year[27] - Earnings per share (EPS) for Q3 2023 was CNY 0.27, compared to CNY 0.65 in Q3 2022, reflecting a decline of 58.5%[28] Cash Flow - Cash flow from operating activities for the year-to-date was ¥103,466,873.32, down 72.12% from the previous year[6] - Cash flow from operating activities generated a net amount of CNY 103,466,873.32, significantly lower than CNY 371,080,631.51 in the previous year[28] - The net cash flow from investment activities was -262,404,309.11 CNY, compared to -292,338,953.77 CNY in the previous period, indicating a decrease in cash outflow[29] - Cash inflow from financing activities totaled 2,106,308,500.00 CNY, significantly higher than 721,564,530.00 CNY in the prior period, reflecting increased borrowing[29] - The net cash flow from financing activities was 1,347,435,526.24 CNY, up from 183,784,044.39 CNY, showing a strong improvement in financing[29] - The total cash and cash equivalents at the end of the period reached 1,714,863,655.79 CNY, compared to 738,727,447.39 CNY at the end of the previous period, indicating a substantial increase[29] - The company received cash from borrowings amounting to 2,087,430,000.00 CNY, compared to 665,996,000.00 CNY previously, indicating a significant increase in financing activities[29] Assets and Liabilities - Total assets increased by 32.52% to ¥5,475,674,094.55 compared to the end of the previous year[6] - The total assets as of September 30, 2023, amount to 5,475,674,094.55 RMB, an increase from 4,131,859,509.89 RMB at the beginning of the year[23] - Total liabilities rose to CNY 2,518,590,317.08, compared to CNY 1,559,684,578.10, marking an increase of about 61.5%[27] - Total equity attributable to shareholders increased to CNY 2,957,083,777.47 from CNY 2,572,174,931.79, reflecting a growth of approximately 15%[27] Research and Development - Research and development expenses rose by 37.26% to ¥59,925,575.60, reflecting increased investment in the "One Vertical, One Horizontal" development strategy[12] - Research and development expenses increased to CNY 59,925,575.60, up from CNY 43,658,283.82, indicating a rise of approximately 37%[27] Shareholder Information - The total number of common shareholders at the end of the reporting period is 28,175[17] - Zhejiang Xiangyun Technology Co., Ltd. holds 26.20% of shares, amounting to 144,376,377 shares, with 74,600,000 shares pledged[17] - As of September 30, 2023, the company repurchased 1,830,300 shares, representing 0.33% of the total share capital[20] - The company plans to use between 100 million and 200 million RMB for share repurchase, with a maximum price of 17 RMB per share[20] Financial Activities - The company issued convertible bonds, raising ¥1,190,000,000, which significantly impacted cash flow from financing activities[15] - The company issued 12 billion RMB of convertible bonds on March 6, 2023, with a face value of 100 RMB per bond[19] - The company received government subsidies amounting to ¥15,514,887.78, a decrease of 37.88% compared to the previous year[12] Inventory and Receivables - Inventory as of September 30, 2023, is 689,726,529.33 RMB, up from 545,874,555.66 RMB at the beginning of the year[23] - Accounts receivable decreased to 155,357,591.10 RMB from 169,398,585.99 RMB[23]